期刊文献+

促红细胞生成素对破骨细胞调控机理的研究 被引量:1

Erythropoietin receptor signaling pathways mediated osteoclast differentiation and activation
下载PDF
导出
摘要 目的研究小鼠单核巨噬细胞在体外向破骨细胞分化的过程中,促红细胞生成素(erythropoietin,EPO)与破骨细胞表面受体Epor结合发挥作用的机理。方法 EPO作用于Epor受体沉默的经诱导的小鼠单核巨噬细胞,观察TRAP阳性多核细胞数目变化。Real-time PCR检测RAW264.7向破骨细胞分化过程中相关基因Epor、Nfatc1、Mmp9、EphrinB2基因的表达。结果与对照组比较,4天后,Epor沉默组的Nfatc1、EphrinB2 mRNA的表达明显升高(P<0.01),Ctsk Mmp9 mRNA的表达明显降低(P<0.01)。结论 EPO通过与破骨细胞表面受体Epor结合,引发破骨细胞内相关基因表达改变,进而影响破骨细胞的分化和活化。 Objective To investigate the mechanism of mediating osteoclast differentiation and activation by erythropoietin. Methods The mouse monocyte/macrophage cell line RAW264. 7 as an osteoclast precursor was treated with rhEpo and receptor activator of nuclear factor- κB (RANK) ligand ( RANKL). The numbers of tartrate-resistant acid phosphatase (TRAP) staining positive and muhinucleated cells were counted after 5-9 days. The levels of Epor, Nfatcl, efnb2, matrix metalloproteinase-9 (Mmp-9) and cathepsin K (Ctsk) were examined by semi-quantitative real-time PCR. Results Compared with the control, the expression of Nfatcl, EphrinB2 mRNA was up-regulated ( P 〈 0. 01 ), and the expression of Ctsk Mmp9 mRNA down-regulated ( P 〈 0.01 ) after four days. Conclusion Eythropoietin combined with osteoclast cell surface receptor Epor, initiated steoclast related gene expression changes, thereby influencing differentiation and activation of osteoclasts.
出处 《北京口腔医学》 CAS 2014年第3期121-124,共4页 Beijing Journal of Stomatology
基金 国家自然科学基金(81271111)
关键词 促红细胞生成素 促红细胞生成素受体 RNAI 破骨细胞 Eythropoietin Epor RNAi Osteoclast
  • 相关文献

参考文献16

  • 1Porter DL Regulation of erythropoietin production. Exp Hematol, 1993,21 (3) :399-404.
  • 2Koury MJ, Bondurant MC. Control of red cell production the roles of programmed cell death ( apoptosis ) and erythropoietin. Transfusion, 1990,30 ( 8 ) : 673-674.
  • 3Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin : A Hormone with Multiple Functions. Pathobiology, 2011,78 ( 1 ) :41-45.
  • 4Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell, 1993, 74 (2) :227-236.
  • 5Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature, 2001,412 ( 6847 ) : 641-647.
  • 6Richmond TD, Chohan M, Barber DL. Barber Turning ceils red: signal transduetion mediated by erythropoietin. Trends in Cell Biology, 2005,15 ( 3 ) : 146-155.
  • 7Mennini T, De Paola M, Bigini P, et al. Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med, 2006 ,12(7-8) :153-160.
  • 8Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA ,2002,99(16) :10659-10664.
  • 9Holstein JH, Menger MD, Scheuer C, et al. Erythropoietin (EPO) : EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci, 2007, 80 ( 10 ) : 893 -900.
  • 10Garcia P, Speidel V, Scheuer C, et al. Low Dose Erythropoietin Stimulates Bone Healing in Mice. Orthop Res,2011,29(2) :165-172.

同被引文献11

引证文献1

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部